Lucid Diagnostics Inc. (LUCD) vs Profound Medical (PROF)
Lucid Diagnostics Inc. and Profound Medical are both Medical Devices companies. Profound Medical is the larger, with a market value of $204.6M against $170.3M — 1.2× the size. Profound Medical grew revenue faster over the last twelve months: 61.2% against 24.9%. Profound Medical has the higher net margin (−171.6% vs −1,193.9%) and the higher return on invested capital (−137.8% vs −3,096.5%). Across the 17 metrics below, Profound Medical leads on 14 and Lucid Diagnostics Inc. on 3.
Valuation
Profitability
| Metric | LUCD | PROF | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | 71.79% | 56.01% |
| Operating margin | (930.84%) | (185.31%) | (15.03%) |
| Net margin | (1,193.87%) | (171.56%) | (20.40%) |
| Free cash flow margin | (866.56%) | (189.15%) | (7.24%) |
| Return on equity | 364.89% | (73.53%) | (15.32%) |
| Return on assets | (167.51%) | (58.44%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (137.78%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack